1Barnett AH.A review of basal insulins[ J].Diabet Med,2003,20(11):873-885.
2Bolli GB.How to ameliorate the problem of hypoglycemia in intensive aswell as non-intensive treatment of type 1 diabetes[ J ].Diabetes Care,1999,(supple 2):B43-B52.
3Chase HP,Lockspeiser T,Peery B,et al.The impact of the diabetes control and complications trial and humanlog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes[ J ].Diabetes Care,2001,24 (3):430-434.
4Howay DC,Bowsher PR,Brunelle RL,et al.[Lys(B28),Pro (B29) ] -human insulin:a rapidly absorbed analogue of human insulin[J].Diabetes,1994,43(3):396-402.
5Osterberg O,Erichsen L,Ingwersen SH,et al.Pharmacokinetic and pharmacodynamic properties of insulin aspart and human insulin[ J ].pharmacokinet pharmacodyn,2003,30 (3):221-235.
6Heller SR,Colagiuri S,Vaaler S,et al.Hypoglycemia with insulin aspart:a double-blind,randomized,crossover trial in subjects with type 1 diabetes[J].Diabet Med,2004,21(7):769-775.
7Marit K,Alicia S,Rejeanne,et al.Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undogoing intensive insulin management using lispro insulin before meals:a randomized,placebo-controlled,crossover trial[J].diabetes care,2003,26(1):9-15.
8Lindholm A,Jensen LB,Home PD,et al.Immune responses to insulin aspart and biphasic insulin aspart in people with type 1and type 2 diabetes[ J ].Diabetes Care,2002,25 (5):876-882.
9Reynolds NA,Wagstaff AJ.Insulin aspart:a review of its use in the management of type 1 or 2diabetes mellitus[ J].Drugs,2004,64(17):1957-1974.
10Wang F,Carabino JM,Vergara CM.Insulin glargine:a systematic review of a long-acting insulin analogue[ J ].Clin Ther,2003,25 (6):1541-1577.
